MP

Michael Porimattathil Avira

Active Director Designated Partner DIN 10174318
DIN 10174318 First appointment May 2023 Primary industry Transportation
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Michael Porimattathil Avira

Data last updated:

Michael Porimattathil Avira is a Designated Partner at Evaliya Bio Technologies Llp (since 2023). The company operates in Transportation.

DIN 10174318
Primary Designation Designated Partner
Industry Transportation
First Appointment 24 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner24 May 20232023Active

Board colleagues of Michael Porimattathil Avira

NameDINCompanyDesignation
Hilda John10501376Evaliya Bio Technologies LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Evaliya Bio Technologies Llp
Premium access

Shareholding and investment profile for Michael Porimattathil Avira

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Michael Porimattathil Avira

Michael Porimattathil Avira currently holds 1 directorship: Evaliya Bio Technologies Llp (Designated Partner, since 24 May 2023).

Michael Porimattathil Avira was first appointed on 24 May 2023 as Designated Partner at Evaliya Bio Technologies Llp.

The current boards of Michael Porimattathil Avira's companies include Hilda John (Evaliya Bio Technologies Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available